The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Complications of obesity
Abstract
Global obesity rates have increased exponentially in recent decades. People are becoming obese younger, morbid obesity is increasing and the full health implications are only beginning to be seen. This article discusses the latest epidemiological data on obesity in adults and children, and systemically reviews the complications associated with the condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It increases the risk for multiple metabolic complications including type 2 diabetes (T2D), metabolic-dysfunction associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease), cardiovascular disease as well as many mechanical complications such as osteoarthritis and obstructive sleep apnoea (OSA) [3].”
From What is the pipeline for future medications for obesity? (2025) · cites this paper as [3]
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072 · cited 1×
“In the USA, the rates of obesity in children has remained steady at 17% from 2003–04 to 2011–12.(4) A review of rates of obesity in 11- to”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Obesity is associated with a state of chronic low-level inflammation, orchestrated by metabolic cells in response to excess nutrients.(29,30) This inflammatory state is present in organs such as the liver, brain, pancreas and adipose tissue and has been implicated in immuno-metabolic disease.”
Background(2016) · The Lancet · doi:10.1016/s0140-6736(16)30054-x · Cited by 5,212 · cited 3×
“The prevalence of overweight and obesity has increased dramatically in recent decades.(1,2) From 1975 to 2014, global rates of obesity (body mass index 30 kg/m(2)) increased from 3.”
BackgroundProspective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754 · cited 1×
“Obesity is associated with a state of chronic low-level inflammation, orchestrated by metabolic cells in response to excess nutrients.(29,30) This inflammatory state is present in organs such as the liver, brain, pancreas and adipose tissue and has been implicated in immuno-metabolic disease.”
BackgroundObesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · cited 1×
“The Framingham Heart Study, which followed 6000 adult subjects without a history of heart failure for a mean of 14 years, found that the risk of heart failure was doubled in obesity.(51) After adjusting for established risk factors, the risk of heart failure increased 5% in men and 7% in women for each extra 1 kg/m(2)…”
MethodVernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074 · cited 1×
“characterized by liver inflammation and injury, which can lead to cirrhosis and hepatocellular carcinoma.(81,82) NAFLD is considered the hepatic manifestation of metabolic syndrome and its risk is strongly correlated with BMI.”
BackgroundYusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
Research works printed but not linked: 3
- McPherson, 2015, Obesity and ischemic heart disease, Am Heart Assoc, 116, 570
- Gozal, 2006, Sleep, A74
- Petta, 2015, Diet, weight loss, and liver health in NAFLD: pathophysiology, evidence and practice, Hepatology, 63, 2032
Cited by
What is the pipeline for future medications for obesity?
Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01473-y · Cited by 332
Gutiérrez-Cuevas, J., Santos, A., & Armendariz-Borunda, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111629 · Cited by 216
“In men, obesity is associated with diminished sperm count and elevated rates of erectile dysfunction [41].”
BackgroundInfluentialAdult obesity complications: challenges and clinical impact
Ansari, S., Haboubi, H., & Haboubi, N. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934955 · Cited by 184
West, S., Scragg, J., Aveyard, P., Oke, J. L., Willis, L., Haffner, S. J. P., Knight, H., Wang, D., Morrow, S., Heath, L., et al. (2026) · BMJ · doi:10.1136/bmj-2025-085304 · Cited by 174
Celastrol in metabolic diseases: Progress and application prospects
Xu, S., Feng, Y., He, W., Xu, W., Xu, W., Yang, H., & Li, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105572 · Cited by 129
Metadata
- Authors
- Kinlen, D., Cody, D., & O’Shea, D.
- Affiliations
- University College Dublin (IE)
- Children's Health Ireland at Crumlin (IE)
- From the Obesity Immunology Group, Education and Research Centre, St Vincent’s University Hospital, University College Dublin, Dublin 4, Ireland
- Corresponding author
- Kinlen, D
- ORCID
- Kinlen, D
- Venue
- QJM: An International Journal of Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-24
- Volume
- 111
- Issue
- 7
- Pages
- 437-443
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2725
- 1460-2393
- OpenAlex
- W2738685362
- Cited by
- 308
- References
- 108
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 67 · 2023: 62 · 2022: 64 · 2021: 26 · 2020: 23 · 2019: 12 · 2018: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- QJM (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Children's Research Centre
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Keywords
- obesity, morbid obesity, obesity complications, obesity epidemiology, childhood obesity, adult obesity
- MeSH terms
- Adult, Cardiovascular Diseases, Child, Diabetes Mellitus, Humans, Mortality, Obesity, Risk Factors, Global Health, Comorbidity, Body Mass Index, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complications of obesity. https://app.cochat.ai/papers/10.1093/qjmed/hcx152
- The paper
- Kinlen, D., Cody, D., & O’Shea, D. (2018). Complications of obesity. QJM: An International Journal of Medicine. https://doi.org/10.1093/qjmed/hcx152
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.